High serum levels of remnant lipoproteins predict ischemic stroke in patients with metabolic syndrome and mild carotid atherosclerosis

Atherosclerosis

Volumn 202, Issue 1, 2009, Pages 234-240

  Nakamura, Takamitsu ^a   Obata, Jun ei ^a   Takano, Hajime ^a   Kawabata, Kenichi ^a   Sano, Keita ^a   Kobayashi, Tsuyoshi ^a   Fujioka, Daisuke ^a   Saito, Yukio ^a   Yano, Toshiaki ^a   Kugiyama, Kiyotaka ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Carotid plaque; Metabolic syndrome; Remnant lipoprotein; Stroke

Indexed keywords

LIPOPROTEIN; REMNANT LIPOPROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

AGED; CAROTID ARTERY DISEASES; CHOLESTEROL; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISCHEMIA; LIPOPROTEINS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK; STROKE; TRIGLYCERIDES;

EID: 57649224409     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.03.018     Document Type: Article

References (23)

1. Grundy S.M., Hansen B., Smith Jr. S.C., et al. American Heart Association; National Heart, Lung, and Blood Institute; American Diabetes Association. Clinical management of the metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 109 (2004) 551-556
2. Tanne D., Koren-Morag N., Graff E., and Goldbourt U. Blood lipids and first-ever ischemic stroke/transient ischemic attack in the Bezafibrate Infarction Prevention (BIP) Registry: high triglycerides constitute an independent risk factor. Circulation 104 (2001) 2892-2897
3. Patel A., Barzi F., Jamrozik K., et al. Asia Pacific Cohort Studies Collaboration. Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region. Circulation 110 (2004) 2678-2686
4. Grønholdt M.L. Ultrasound and lipoproteins as predictors of lipid-rich, rupture-prone plaques in the carotid artery. Arterioscler Thromb Vasc Biol 19 (1999) 2-13
5. Kugiyama K., Doi H., Motoyama T., et al. Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries. Circulation 97 (1998) 2519-2526
6. Kugiyama K., Doi H., Takazoe K., et al. Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. Circulation 99 (1999) 2858-2860
7. Nakamura T., Takano H., Umetani K., et al. Remnant lipoproteinemia is a risk factor for endothelial vasomotor dysfunction and coronary artery disease in metabolic syndrome. Atherosclerosis 181 (2005) 321-327
8. Nakajima K., Saito T., Tamura A., et al. Cholesterol in remnant like lipoproteins in human serum using monoclonal anti apo B-100 and anti apoA-I immunoaffinity mixed gels. Clin Chim Acta 223 (1993) 53-71
9. Fukushima H., Sugiyama S., Honda O., et al. Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type II diabetes mellitus. J Am Coll Cardiol 43 (2004) 2219-2224
10. Barzilai B., Saffitz J.E., Miller J.G., and Sobel B.E. Quantitative ultrasonic characterization of the nature of atherosclerotic plaques in human aorta. Circ Res 60 (1987) 459-512
11. Shepard R.K., Miller J.G., and Wickline S.A. Quantification of atherosclerotic composition in cholesterol-fed rabbits with 50-MHz acoustic microscopy. Arterioscler Thromb 12 (1992) 1227-1234
12. Grønholdt M.L., Nordestgaard B.G., Schroeder T.V., Vorstrup S., and Sillesen H. Ultrasonic echolucent carotid plaques predict future strokes. Circulation 104 (2001) 68-73
13. Takiuchi S., Rakugi H., Honda K., et al. Quantitative ultrasonic tissue characterization can identify high-risk atherosclerotic alteration in human carotid arteries. Circulation 102 (2000) 766-770
14. Mathiesen E.B., Bønaa K.H., and Joakimsen O. Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis: the Tromso study. Circulation 103 (2001) 2171-2175
15. Honda O., Sugiyama S., Kugiyama K., et al. Echolucent carotid plaques predict future coronary events in patients with coronary artery disease. J Am Coll Cardiol 43 (2004) 1177-1184
16. Watanabe K., Sugiyama S., Kugiyama K., et al. Stabilization of carotid atheroma assessed by quantitative ultrasound analysis in nonhypercholesterolemic patients with coronary artery disease. J Am Coll Cardiol 46 (2005) 2022-2030
17. The Examination Committee of Criteria for 'Obesity Disease' in Japan, Japan Society for the Study of Obesity. New criteria for 'obesity disease' in Japan. Circ J 2002;66:987-92.
18. Chaturvedi S., Bruno A., Feasby T., et al. Therapeutics and Technology Assessment Subcommittee of the American Academy Neurology. Carotid endarterectomy-an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 65 (2005) 794-801
19. Sacco R.L., Adams R., Albers G., et al. American Heart Association/American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack. Circulation 113 (2006) e409-e449
20. White H., Boden-Albala B., Wang C., et al. Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan study. Circulation 111 (2005) 1327-1331
21. Handa N., Matsumoto M., Maeda H., Hougaku H., and Kamada T. Ultrasonic evaluation of early carotid atherosclerosis. Stroke 21 (1990) 1567-1572
22. Doi H., Kugiyama K., Oka H., et al. Remnant lipoproteins induce proatherothrombogenic molecules in endothelial cells through a redox-sensitive mechanism. Circulation 102 (2000) 670-676
23. Kishi K., Ochiai K., Ohta Y., et al. Highly sensitive cholesterol assay with enzymatic cycling applied to measurement of remnant lipoprotein-cholesterol in serum. Clin Chem 48 (2002) 737-741